The National Institutes of Health (NIH) are funding R21 exploratory/development research grants that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to kidney disease research. Studies should address important clinical and translational questions and are potentially of high clinical and public health impact. These grants will award up to $275,000 over two years. The deadline for the next funding cycle is September 7. Read the full announcement.